Eugen Mengel

1.1k total citations
21 papers, 482 citations indexed

About

Eugen Mengel is a scholar working on Physiology, Cell Biology and Molecular Biology. According to data from OpenAlex, Eugen Mengel has authored 21 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 7 papers in Cell Biology and 6 papers in Molecular Biology. Recurrent topics in Eugen Mengel's work include Lysosomal Storage Disorders Research (19 papers), Cellular transport and secretion (7 papers) and Trypanosoma species research and implications (4 papers). Eugen Mengel is often cited by papers focused on Lysosomal Storage Disorders Research (19 papers), Cellular transport and secretion (7 papers) and Trypanosoma species research and implications (4 papers). Eugen Mengel collaborates with scholars based in United States, France and Germany. Eugen Mengel's co-authors include Roberto Giugliani, Simon Jones, Nathalie Guffon, Paul Harmatz, Melissa Wasserstein, Margaret M. McGovern, Bruno Bembi, Pramod K. Mistry, Christian J. Hendriksz and Vassili Valayannopoulos and has published in prestigious journals such as Brain, The Journal of Pediatrics and Archives of Disease in Childhood.

In The Last Decade

Eugen Mengel

20 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eugen Mengel United States	9	430	144	132	98	61	21	482
Alexander Broomfield United Kingdom	14	358 0.8×	205 1.4×	124 0.9×	137 1.4×	54 0.9×	54	613
Karen Tylee United Kingdom	16	580 1.3×	104 0.7×	259 2.0×	158 1.6×	107 1.8×	45	704
Norberto Guelbert Argentina	16	514 1.2×	148 1.0×	216 1.6×	232 2.4×	105 1.7×	39	651
Julie Simon United States	8	234 0.5×	82 0.6×	118 0.9×	76 0.8×	55 0.9×	8	429
MA Cleary United Kingdom	7	264 0.6×	61 0.4×	119 0.9×	86 0.9×	46 0.8×	9	364
Li‐Ping Tsai Taiwan	13	178 0.4×	160 1.1×	121 0.9×	93 0.9×	25 0.4×	45	583
S. Wendt Germany	4	526 1.2×	65 0.5×	281 2.1×	178 1.8×	86 1.4×	8	588
M. Smith United Kingdom	4	387 0.9×	35 0.2×	165 1.3×	166 1.7×	26 0.4×	5	454
Kyle Rudser United States	12	363 0.8×	41 0.3×	155 1.2×	93 0.9×	66 1.1×	39	460
Taiane Alves Vieira Brazil	10	373 0.9×	37 0.3×	178 1.3×	152 1.6×	62 1.0×	19	444

Countries citing papers authored by Eugen Mengel

Since Specialization

Citations

This map shows the geographic impact of Eugen Mengel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugen Mengel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugen Mengel more than expected).

Fields of papers citing papers by Eugen Mengel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugen Mengel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugen Mengel. The network helps show where Eugen Mengel may publish in the future.

Co-authorship network of co-authors of Eugen Mengel

This figure shows the co-authorship network connecting the top 25 collaborators of Eugen Mengel. A scholar is included among the top collaborators of Eugen Mengel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugen Mengel. Eugen Mengel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schiffmann, Raphael, James Turnbull, Ruth Pulikottil-Jacob, et al.. (2025). Gaucher disease type 3 from infancy through adulthood: a conceptual model of signs, symptoms, and impacts associated with ataxia and cognitive impairment. Orphanet Journal of Rare Diseases. 20(1). 171–171. 1 indexed citations

Héron, Bénédicte, Spyros Batzios, Eugen Mengel, et al.. (2024). A natural history study of pediatric patients with early onset of GM1 gangliosidosis, GM2 gangliosidoses, or gaucher disease type 2 (RETRIEVE). Orphanet Journal of Rare Diseases. 19(1). 459–459. 1 indexed citations

Schiffmann, Raphael, Eugen Mengel, Mary Wallace, et al.. (2024). Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP). Advances in Therapy. 41(7). 2907–2923. 7 indexed citations

Ries, Markus, et al.. (2022). Quantitative longitudinal natural history of 8 gangliosidoses—conceptual framework and baseline data of the German 8-in-1 disease registry. A cross-sectional analysis. Genetics in Medicine. 24(12). 2434–2443. 1 indexed citations

Schiffmann, Raphael, Timothy M. Cox, Jean-François Dedieu, et al.. (2022). Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial. Brain. 146(2). 461–474. 26 indexed citations

Díaz, George A., Simon Jones, Maurizio Scarpa, et al.. (2021). One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency. Genetics in Medicine. 23(8). 1543–1550. 50 indexed citations

McGovern, Margaret M., Melissa Wasserstein, Bruno Bembi, et al.. (2021). Prospective study of the natural history of chronic acid sphingomyelinase deficiency in children and adults: eleven years of observation. Orphanet Journal of Rare Diseases. 16(1). 212–212. 31 indexed citations

Dimachkie, Mazen M., Richard J. Barohn, Barry J. Byrne, et al.. (2021). NEO1/NEO-EXT studies: Safety and exploratory efficacy of repeat avalglucosidase alfa dosing after up to 6 years in participants with late-onset pompe disease (LOPD). Molecular Genetics and Metabolism. 132(2). S34–S34. 1 indexed citations

Schiffmann, Raphael, Timothy M. Cox, Hiroyuki Ida, et al.. (2020). Venglustat combined with imiglucerase positively affects neurological features and brain connectivity in adults with Gaucher disease type 3. Molecular Genetics and Metabolism. 129(2). S144–S145. 4 indexed citations

10.

Dimachkie, Mazen M., Richard J. Barohn, Barry J. Byrne, et al.. (2020). NEO1 and NEO-EXT studies: Long-term safety and exploratory efficacy of repeat avalglucosidase alfa dosing for 5.5 years in late-onset Pompe disease patients. Molecular Genetics and Metabolism. 129(2). S49–S49. 3 indexed citations

11.

Schoser, Benedikt, Richard J. Barohn, Barry J. Byrne, et al.. (2020). AUTOPHAGIC MYOPATHIES / MYOFIBRILLAR MYOPATHIES / DISTAL MYOPATHIES / POMPE DISEASE. Neuromuscular Disorders. 30. S49–S49.

12.

Dimachkie, Mazen M., Richard J. Barohn, Priya S. Kishnani, et al.. (2019). NEO1 AND NEO-EXT STUDIES: PHARMACODYNAMIC/EXPLORATORY BIOMARKER AND SAFETY ASSESSMENTS FOLLOWING REPEAT AVALGLUCOSIDASE ALFA DOSING FOR UP TO 4.5 YEARS IN PATIENTS WITH LATE-ONSET POMPE DISEASE. 60. 1 indexed citations

13.

Whitley, Chester B., Maureen Cleary, Eugen Mengel, et al.. (2018). Observational Prospective Natural History of Patients with Sanfilippo Syndrome Type B. The Journal of Pediatrics. 197. 198–206.e2. 25 indexed citations

14.

Eisengart, Julie B., Kyle Rudser, Yong Xue, et al.. (2018). Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison. Genetics in Medicine. 20(11). 1423–1429. 43 indexed citations

15.

McGovern, Margaret M., Carlo Dionisi‐Vici, Roberto Giugliani, et al.. (2017). Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency. Genetics in Medicine. 19(9). 967–974. 66 indexed citations

16.

Imrie, Jackie, Eugen Mengel, David Cassiman, et al.. (2016). Cause of death in patients with attenuated acid sphingomyelinase deficiency: Comprehensive literature review and report of new cases. Molecular Genetics and Metabolism. 117(2). S60–S60. 2 indexed citations

17.

Cassiman, David, Seymour Packman, Bruno Bembi, et al.. (2016). Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): Literature review and report of new cases. Molecular Genetics and Metabolism. 118(3). 206–213. 74 indexed citations

18.

Harmatz, Paul, Eugen Mengel, Roberto Giugliani, et al.. (2014). Longitudinal analysis of endurance and respiratory function from a natural history study of Morquio A syndrome. Molecular Genetics and Metabolism. 114(2). 186–194. 31 indexed citations

19.

Harmatz, Paul, Eugen Mengel, Roberto Giugliani, et al.. (2013). The Morquio A Clinical Assessment Program: Baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects. Molecular Genetics and Metabolism. 109(1). 54–61. 110 indexed citations

20.

Hendriksz, Christian J., Barbara K. Burton, Thomas R. Fleming, et al.. (2013). A multi-national, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of BMN 110 treatment for mucopolysaccharidosis IVA (Morquio syndrome type A). Molecular Genetics and Metabolism. 108(2). S48–S48. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact